Clinical outcome of breast cancer (BC) patients (pts) with pT1N0M0 disease

被引：0
|
作者：
Basaran, Gul Atalay [1 ]
Ekenel, Meltem [1 ]
Demirkalem, Pakize [1 ]
Cakir, Tebessum [1 ]
Gulluoglu, Bahadir [1 ]
Gumus, Mahmut [2 ]
Dane, Faysai [1 ]
Iyikesici, Salih [1 ]
Yumuk, Fulden [1 ]
Turhal, Serdar [1 ]
机构：
[1] Marmara Univ Hosp, Istanbul, Turkey
[2] Kartal Lutfu Kirdar Educ & Res Hosp, Istanbul, Turkey
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [41] Adjuvant radiotherapy in combined treatment of breast cancer T1-2N0-1M0
    Musabaeva, L.I.
    Zhogina, Zh.A.
    Slonimskaya, E.M.
    [J]. Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost', 2002, 47 (04): : 55 - 62
  • [42] Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
    Huang, Jiao-Bao
    Lu, Jun
    Wu, Dong
    Xu, Bin-bin
    Xue, Zhen
    Lin, Guo-Sheng
    Zheng, Hua-Long
    Shen, Li-Li
    Lin, Jia
    Xie, Jian-Wei
    Wang, Jia-Bin
    Lin, Jian-Xian
    Chen, Qi-Yue
    Cao, Long-Long
    Zheng, Chao-Hui
    Huang, Chang-Ming
    Li, Ping
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [43] pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Michel Bolla
    Laurence Collette
    [J]. Nature Reviews Urology, 2009, 6 : 410 - 412
  • [44] Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy
    Garassino, I.
    Gullo, G.
    Orefice, S.
    Tondulli, L.
    Masci, G.
    Salvini, P.
    Eboli, M.
    Di Tommaso, L.
    Giordano, L.
    Alloisio, M.
    Roncalli, M.
    Santoro, A.
    [J]. BREAST, 2009, 18 (04): : 263 - 266
  • [45] Very low risk of early relapse in patients with T1N0M0 breast cancer (BC) after surgery and adjuvant treatments in a single-institution experience
    Garassino, I.
    Gullo, G.
    Tondulli, L.
    Salvini, P.
    Orefice, S.
    Alloisio, M.
    Eboli, M.
    Masci, G.
    Santoro, A.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 9 - 9
  • [46] Suggestions for follow-up (FU) strategies according to the risk of recurrence in patients with T1N0M0 breast cancer (BC): a single-institution experience
    Gullo, G.
    Garassino, I.
    Tondulli, L.
    Salvini, P.
    Masci, G.
    Orefice, S.
    Alloisio, M.
    Eboli, M.
    Santoro, A.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 109 - 109
  • [47] Ukrain therapy of stage T1N0M0 bladder cancer patients
    Uglianitsa, KN
    Nechiporenko, NA
    Nefyodov, LI
    Brzosko, WJ
    [J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1998, 24 (5-6) : 227 - 230
  • [48] Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay
    Zhang, Lina
    Zhou, Mengli
    Liu, Yueping
    Du, Furong
    Tang, Jiyu
    Wang, Ning
    Song, Chao
    Geng, Cuizhi
    Duan, Huijun
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (10) : 1801 - 1808
  • [49] Follow-up of Patients Treated for pT1aN0M0 Breast Cancer: 10-year Survival and Prognostic Factors
    Crochet, Patrice
    Molinari, Nicolas
    Darmon, Jean-Claude
    Cutuli, Bruno
    Serin, Daniel
    [J]. BREAST JOURNAL, 2016, 22 (03): : 363 - 365
  • [50] PROSTATE CANCER pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Bolla, Michel
    Collette, Laurence
    [J]. NATURE REVIEWS UROLOGY, 2009, 6 (08) : 410 - 412
12345